TIBER CREEK GROUP

Lobbying for AMGEN INC

Filing 3rd Quarter - Report

3rd Quarter (July 1 - Sep 30) 2025 · District of Columbia · House · Senate · $60,000.00 income · posted Oct 19, 2025

Lobbying activity 2

Medicare/Medicaid

Issues related to Medicare and Medicaid drug pricing; Issues related to biosimilar access and affordability.

Health Issues

Issues related to the 340B Program - Public Health Service Act (P.L. 78-410).

Source: federal Lobbying Disclosure Act filing. Bills are parsed from the activity descriptions.